Studies on monoclonal anti-idiotypic antibodies to human B cell leukemia

Abstract

Murine immunocytoma cell line, NS-1, was fused with spleen cells of Balb/C mice which had been stimulated by tolerogenic disaggregated human gamma globulin and immunized by purified serum IgM from the patient with chronic B cell leukemia (B-CLL). 10 hybridoma cell lines secreting monoclonal anti-idiotype (anti-Id) antibodies to human CLL were obtained. The McAbs were subclasses belonging to IgM and of IgG mouse. Specificity and biologic characters of the monoclonal anti-Id antibodies from culture fluid or ascites were assayed by ELISA, indirect mixed ELISA sandwich, ELISA inhibition, immunofluorescence (IF) and IF inhibition. The study also proved that monoclonal anti-Id antibodies could react with homologous IgM, but not with Ig from normal donors or a panel of patients with myeloma. The results of IF and IF inhibition assay showed that monoclonal anti-Id antibodies were bound to lymphocytes of patient with B-CLL. Their reactivity was inhibited by homologous IgM, but not by lymphocytes of patients with ALL or lymphoma. Monoclonal anti-Id antibodies were heterogenous reactive patterns with cell lines in vitro.

Keywords

B-CLL / B cell hybridization / monoclonal anti-Id antibodies / immuno globulin / cell surface markers

References

[1] I IgG McAb 1990(1)

[2] McAb,I. McAb

[3] McAb 1988; 4:299–301.

[4] StevenLG, et al. . Evaluation of alternative methodologies for the generation of murine monoclonal anti-idiotypic antibodies to human B cell leukemia and lymphoma. J Immunol Methods, 1986, 89: 1-7

[5] SusumuS, et al. . Leukemic lymphosarcoma with monoclonal IgM: Idiotypic specificity on the cell surface and in the cytoplasm of lymphosarcoma cells. Blood, 1978, 52: 922-7

[6] Dörken B, et al. Therapie mit monoklonalen anti-idiotypischen Antikörpern bei einem Patienten mit progredientem Immunozytom. Klin Wchschr 1986;: 105.

[7] BrownS, et al. . Immunoglobulin secretion by mouse X human hybridomas: An approach for the production of antiidiotypic reagents useful in monitoring patients with B cell lymphoma. J Immunol, 1980, 125: 1037-22